Engineers build mini drug-producing biofactories in yeast

August 15, 2008

Researchers at the California Institute of Technology have developed a novel way to churn out large quantities of drugs, including antiplaque toothpaste additives, antibiotics, nicotine, and even morphine, using mini biofactories--in yeast.

A paper describing the research, now available online, will be featured as the cover article of the September issue of Nature Chemical Biology.

Christina D. Smolke, an assistant professor of chemical engineering at Caltech, along with graduate student Kristy Hawkins, genetically modified common baker's yeast (Saccharomyces cerevisiae) so that it contained the genes for several plant enzymes. The enzymes allow the yeast to produce a chemical called reticuline, which is a precursor for many different classes of benzylisoquinoline alkaloid (BIA) molecules. The BIA molecules are a large group of chemically intricate compounds, such as morphine, nicotine, and codeine, which are naturally produced by plants.

BIA molecules exhibit a wide variety of pharmacological activities, including antispasmodic effects, pain relief, and hair growth acceleration. Other BIAs have shown anticancer, antioxidant, antimalarial, and anti-HIV potential.

"There are estimated to be thousands of members in the BIA family, and having a source for obtaining large quantities of specific BIA molecules is critical to gaining access to the diverse functional activities provided by these molecules," says Smolke, whose lab focuses on using biology as a technology for the synthesis of new chemicals, materials, and products. However, the natural plant sources of BIAs accumulate only a small number of the molecules, usually "end products" like morphine and codeine that, while valuable, can't be turned into other compounds, thus limiting the availability of useful new products.

To their reticuline-producing yeast, Smolke and Hawkins added the genes for other enzymes, from both plants and humans, which allowed the yeast to efficiently generate large quantities of the precursors for sanguinarine, a toothpaste additive with antiplaque properties; berberine, an antibiotic; and morphine.

The researchers are now in the process of engineering their yeast so that they will turn these precursor molecules into the final, pharmacologically useful molecules. "But even the intermediate molecules that we are producing can exhibit important and valuable activities, and a related area of research will be to examine more closely the pharmacological activities of these metabolites and derivatives now that pure sources can be obtained," says Smolke, who estimates that her system could be used for the large-scale manufacture of BIA compounds in one to three years.

Smolke and Hawkins also plan to extend their research to the production of BIAs that don't normally exist in nature.

"If one thinks of these molecules as encoding functions that are of interest to us, the ability to produce nonnatural alkaloids will provide access to more diverse functions and activities. By expanding to nonnatural alkaloids, we can search for molecules that provide enhanced activities, new activities, and not be limited by the activities that have been selected for in nature," says Smolke.

"Our work has the potential to result in new therapeutic drugs for a broad range of diseases. This work also provides an exciting example of the increased complexity with which we are engineering biological systems to address global societal challenges," she says.

Source: California Institute of Technology


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4.6 /5 (25 votes)

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • Going - Aug 15, 2008
    • Rank: 5 / 5 (1)
    What happens if the yeast escapes and enters the food chain?

    I prefer the use of single celled GM organisms to complex multicellular ones but I think -precautions still need to be made to ensure the yeast is not viable in the wild.
  • NeilFarbstein - Aug 15, 2008
    • Rank: 1 / 5 (1)
    What if it get into a bakery? Your bread might have morphine in it by accident.
  • gmurphy - Aug 16, 2008
    • Rank: not rated yet
    all life on this planet struggles for existance, if a GM lifeform gets released into the wild, it is at a distinct disadvantage to natural lifeforms because so much of its genome has been redirected to meet our needs.
  • superhuman - Aug 16, 2008
    • Rank: not rated yet
    The ultimate goal is to clone the genes needed to produce LSD, psilocybin, THC, DMT and others into common pests and then spread them around the globe to allow everyone the freedom of choice.

    Unlimited access to drugs should end that moronic war on drugs so that all the money now happily appropriated by a band of useless parasites can be spent on drug research and education.

    Substances like LSD offer everyone a chance of becoming a better human being - more aware of themselves, with better understanding of reality and most importantly with much more control over their lives then standard social imprinting which we all undergo during growing up allows.

    I consider banning LSD and related compounds one of the worst crimes against humanity ever committed.
  • ProfO - Apr 20, 2009
    • Rank: not rated yet
    There are cases of gm plants (corn I think) that has moved into the DNA of it's indiginous predecessor by cross-crop biotic pollination, carrying unwanted genetic characteristics. I think it was Journal of Science several years ago and something to do with indigenous Mexican corn.

August 15, 2008 all stories

Comments: 5

4.6 /5 (25 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories



Other News

New chemical reaction offers opportunities for drug development

Chemistry / Biochemistry

created 3 minutes ago | popularity not rated yet | comments 0

Researchers led by Conway Fellow, Professor Pat Guiry have solved a chemistry problem that has stumped researchers worldwide for more than a decade. The results have earned the group the cover story of the leading scientific ...


Sandia CR5

Machine Converts CO2 into Gasoline, Diesel, and Jet Fuel

Chemistry / Biochemistry

created Nov 23, 2009 | popularity 4.6 / 5 (30) | comments 19

(PhysOrg.com) -- Researchers at Sandia National Laboratories have built a machine that uses the sun's energy to convert carbon dioxide waste from power plants into transportation fuels such as gasoline, diesel, ...


New hydrogen-storage method discovered

New hydrogen-storage method discovered

Chemistry / Materials Science

created Nov 22, 2009 | popularity 4.3 / 5 (42) | comments 15

Scientists at the Carnegie Institution have found for the first time that high pressure can be used to make a unique hydrogen-storage material. The discovery paves the way for an entirely new way to approach ...


New on-off 'switch' triggers and reverses paralysis in animals with a beam of light

New on-off 'switch' triggers and reverses paralysis in animals with a beam of light (w/ Video)

Chemistry / Biochemistry

created Nov 18, 2009 | popularity 4.8 / 5 (5) | comments 4

In an advance with overtones of Star Trek phasers and other sci-fi ray guns, scientists in Canada are reporting development of an internal on-off "switch" that paralyzes animals when exposed to a beam of ultraviolet ...


Blocking biofilms: Alzheimer's research sheds light on potential treatments for urinary tract infections

Chemistry / Biochemistry

created Nov 25, 2009 | popularity 5 / 5 (1) | comments 0

(PhysOrg.com) -- Research into Alzheimer's disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that's what scientists at Washington University School of Medicine in St. Louis ...